{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:57:58Z","timestamp":1787500678514,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","award":["2020-VICO-279314"],"award-info":[{"award-number":["2020-VICO-279314"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["4845-303"],"award-info":[{"award-number":["4845-303"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme \u2013 Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPND2021- 00694"],"award-info":[{"award-number":["JPND2021- 00694"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["435642\/2018-9"],"award-info":[{"award-number":["435642\/2018-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312410\/20182"],"award-info":[{"award-number":["312410\/20182"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["409066\/2022-2"],"award-info":[{"award-number":["409066\/2022-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312306\/2021-0"],"award-info":[{"award-number":["312306\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["5 P01 AG025204-17"],"award-info":[{"award-number":["5 P01 AG025204-17"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AARFD-23-1150249"],"award-info":[{"award-number":["AARFD-23-1150249"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["24AARFD-1243899"],"award-info":[{"award-number":["24AARFD-1243899"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG073267"],"award-info":[{"award-number":["R01AG073267"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG075336"],"award-info":[{"award-number":["R01AG075336"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011471","name":"National Academy of Neuropsychology","doi-asserted-by":"publisher","award":["#AARF21-850325"],"award-info":[{"award-number":["#AARF21-850325"]}],"id":[{"id":"10.13039\/100011471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011471","name":"National Academy of Neuropsychology","doi-asserted-by":"publisher","award":["ALZ-NAN-22-928381"],"award-info":[{"award-number":["ALZ-NAN-22-928381"]}],"id":[{"id":"10.13039\/100011471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011471","name":"National Academy of Neuropsychology","doi-asserted-by":"publisher","award":["2021-03244"],"award-info":[{"award-number":["2021-03244"]}],"id":[{"id":"10.13039\/100011471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["RDAPB-201809-2016615"],"award-info":[{"award-number":["RDAPB-201809-2016615"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-00915"],"award-info":[{"award-number":["2017-00915"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR21C1003"],"award-info":[{"award-number":["HR21C1003"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A5A2026045"],"award-info":[{"award-number":["NRF-2019R1A5A2026045"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","award":["NIRG-12-92-92090"],"award-info":[{"award-number":["NIRG-12-92-92090"]}],"id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012479","name":"Weston Brain Institute","doi-asserted-by":"publisher","award":["NIRP-12-259245"],"award-info":[{"award-number":["NIRP-12-259245"]}],"id":[{"id":"10.13039\/100012479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARFD-23-1150249"],"award-info":[{"award-number":["AARFD-23-1150249"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["24AARFD-1243899"],"award-info":[{"award-number":["24AARFD-1243899"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARFD-22-974627"],"award-info":[{"award-number":["AARFD-22-974627"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARFD-22-923814"],"award-info":[{"award-number":["AARFD-22-923814"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AACSFD-23-1151197"],"award-info":[{"award-number":["AACSFD-23-1151197"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","award":["UKDRI-1003"],"award-info":[{"award-number":["UKDRI-1003"]}],"id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","award":["FO2022-0270"],"award-info":[{"award-number":["FO2022-0270"]}],"id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009745","name":"Emil och Wera Cornells Stiftelse","doi-asserted-by":"publisher","award":["2022-01018"],"award-info":[{"award-number":["2022-01018"]}],"id":[{"id":"10.13039\/501100009745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009745","name":"Emil och Wera Cornells Stiftelse","doi-asserted-by":"publisher","award":["2019-02397"],"award-info":[{"award-number":["2019-02397"]}],"id":[{"id":"10.13039\/501100009745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018860","name":"Instituto de Ci\u00eancia e Tecnologia de Nanomateriais de Carbono","doi-asserted-by":"publisher","award":["465671\/2014-4"],"award-info":[{"award-number":["465671\/2014-4"]}],"id":[{"id":"10.13039\/501100018860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["AARGD- 21-850670"],"award-info":[{"award-number":["AARGD- 21-850670"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004263","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio Grande do Sul","doi-asserted-by":"publisher","award":["21\/2551-0000673-0"],"award-info":[{"award-number":["21\/2551-0000673-0"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-742881"],"award-info":[{"award-number":["AF-742881"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["FO2017-0243"],"award-info":[{"award-number":["FO2017-0243"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013275","name":"Instituto Serrapilheira","doi-asserted-by":"publisher","award":["Serra-1912-31365"],"award-info":[{"award-number":["Serra-1912-31365"]}],"id":[{"id":"10.13039\/501100013275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tjpad.2025.100205","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:51:46Z","timestamp":1749052306000},"page":"100205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Sarah","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-9829","authenticated-orcid":false,"given":"Pamela C. L","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-3373","authenticated-orcid":false,"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-6569","authenticated-orcid":false,"given":"Guilherme","family":"Povala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9232-7371","authenticated-orcid":false,"given":"Francieli","family":"Rohden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-3830","authenticated-orcid":false,"given":"Cristiano Schaffer","family":"Aguzzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Zalzale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2183-1551","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferrari-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas T.","family":"Leffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-4825","authenticated-orcid":false,"given":"Firoza Z.","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-4495","authenticated-orcid":false,"given":"Carolina","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-557X","authenticated-orcid":false,"given":"Guilherme","family":"Bauer-Negrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markley Silva","family":"Oliveira-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7794-6588","authenticated-orcid":false,"given":"Matheus Scarpatto","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4926-9081","authenticated-orcid":false,"given":"Pampa","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-5472","authenticated-orcid":false,"given":"Emma","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4237-4565","authenticated-orcid":false,"given":"Marina Scop","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2711-3833","authenticated-orcid":false,"given":"C\u00e9cile","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Servaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Tudorascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9286-0694","authenticated-orcid":false,"given":"Helmet","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Hyung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Woong","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0053","authenticated-orcid":false,"given":"Eduardo R","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Joon","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2025.100205_bib0001","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3233\/JAD-240008","article-title":"Biomarkers as endpoints in clinical trials for Alzheimer\u2019s disease","volume":"99","author":"Elghanam","year":"2024","journal-title":"J Alzheimer's Dis"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100205_bib0002","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/YCO.0000000000000851","article-title":"Plasma biomarkers for neurodegenerative disorders: ready for prime time?","volume":"36","author":"Balogun","year":"2023","journal-title":"Curr Opin Psychiatry"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma biomarkers of Alzheimer's Disease: a review of available assays, recent developments, and implications for clinical practice","volume":"7","author":"Pais","year":"2023","journal-title":"J Alzheimers Dis Rep"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100205_bib0004","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","article-title":"Current state of Alzheimer's fluid biomarkers","volume":"136","author":"Molinuevo","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100205_bib0005","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100205_bib0006","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease","volume":"17","author":"Simr\u00e9n","year":"2021","journal-title":"Alzheimer's Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0007","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","article-title":"The future of blood-based biomarkers for Alzheimer's disease","volume":"10","author":"Henriksen","year":"2014","journal-title":"Alzheimer's Dement"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100205_bib0008","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.tjpad.2025.100205_bib0009","first-page":"14","article-title":"Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment","author":"Kivis\u00e4kk","year":"2023","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100205_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.8214","article-title":"Evaluation of plasma biomarkers for A\/T\/N classification of Alzheimer Disease among adults of Caribbean Hispanic ethnicity","volume":"6","author":"Honig","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"24","key":"10.1016\/j.tjpad.2025.100205_bib0011","first-page":"e2944","article-title":"Astrocyte biomarkers in Alzheimer disease","volume":"96","author":"Bellaver","year":"2021","journal-title":"Syst Rev Meta-anal"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100205_bib0012","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/brain\/awae104","article-title":"Blood GFAP reflects astrocyte reactivity to Alzheimer\u2019s pathology in post-mortem brain tissue","volume":"147","author":"Limberger","year":"2024","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100205_bib0013","article-title":"Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia: diagnosis","volume":"15","author":"Ally","year":"2023","journal-title":"Assess Dis Monit"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0014","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100205_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","article-title":"Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression","volume":"69","author":"Shen","year":"2023","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0016","article-title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology","volume":"14","author":"Shir","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100205_bib0017","first-page":"90","author":"Montoliu-Gaya","year":"2023","journal-title":"Plasma Cerebrospinal Fluid Glial Fibrillary Acidic Protein Lev Adults Down Syndr.: Longitud. Cohort Study. Ebiomed"},{"issue":"1\u20132","key":"10.1016\/j.tjpad.2025.100205_bib0018","first-page":"22","article-title":"Outcomes assessment in clinical trials of Alzheimer's Disease and its precursors: readying for short-term and long-term clinical trial needs","volume":"14","author":"Posner","year":"2017","journal-title":"Innov Clin Neurosci"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100205_bib0019","doi-asserted-by":"crossref","first-page":"563","DOI":"10.14283\/jpad.2022.87","article-title":"The future is now: advancing blood-based markers","volume":"9","author":"Carrillo","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100205_bib0020","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.tjpad.2025.100205_bib0021","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207115","article-title":"Potential utility of plasma P-tau and neurofilament light chain as surrogate biomarkers for preventive clinical trials","author":"Ferreira","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0022","article-title":"Discriminative accuracy of the A\/T\/N scheme to identify cognitive impairment due to Alzheimer's disease","volume":"15","author":"Pascoal","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100205_bib0023","doi-asserted-by":"crossref","first-page":"100","DOI":"10.30773\/pi.2021.0335","article-title":"Baseline clinical and biomarker characteristics of Biobank innovations for Chronic cerebrovascular disease with Alzheimer\u2019s Disease study: BICWALZS","volume":"19","author":"Roh","year":"2022","journal-title":"Psychiatry Investig"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100205_bib0024","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1038\/s41380-022-01728-y","article-title":"Independent replication of advanced brain age in mild cognitive impairment and dementia: detection of future cognitive dysfunction","volume":"27","author":"Karim","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.tjpad.2025.100205_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1225816","article-title":"Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer's disease spectrum","volume":"15","author":"Belasso","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100205_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45175","article-title":"Neuropsychiatric symptoms and microglial activation in patients with Alzheimer Disease","volume":"6","author":"Schaffer Aguzzoli","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100205_bib0027","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100205_bib0028","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100205_bib0029","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0030","doi-asserted-by":"crossref","first-page":"1-15.e1-4","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13195-021-00836-1","article-title":"Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach","volume":"13","author":"Royse","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100205_bib0032","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100205_bib0033","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","article-title":"Longitudinal tau PET in ageing and Alzheimer\u2019s disease","volume":"141","author":"Jack","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0034","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neurobiolaging.2012.03.006","article-title":"Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative","volume":"34","author":"Grill","year":"2013","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100205_bib0035","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","article-title":"Longitudinal tau PET in ageing and Alzheimer's disease","volume":"141","author":"Jack","year":"2018","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.tjpad.2025.100205_bib0036","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.scib.2023.07.009","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: a multicenter-based cross-sectional and longitudinal study in China","volume":"68","author":"Gao","year":"2023","journal-title":"Sci Bull"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100205_bib0037","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1212\/WNL.0000000000201289","article-title":"Longitudinal changes in blood biomarkers of clinical alzheimer disease in a biracial population sample","volume":"100","author":"Rajan","year":"2023","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100205_bib0038","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s43587-023-00404-2","article-title":"Towards a future where Alzheimer\u2019s disease pathology is stopped before the onset of dementia","volume":"3","author":"van der Flier","year":"2023","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0039","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100205_bib0040","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0041","article-title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology","volume":"14","author":"Shir","year":"2022","journal-title":"Alzheimer's Dement: Diagn Assess Dis Monit"},{"issue":"12","key":"10.1016\/j.tjpad.2025.100205_bib0042","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jamaneurol.2022.3392","article-title":"Association of Donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial","volume":"79","author":"Pontecorvo","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.tjpad.2025.100205_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Dyck","year":"2023","journal-title":"New Eng J Med"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100205_bib0044","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ana.25874","article-title":"Remote blood biomarkers of longitudinal cognitive outcomes in a population study","volume":"88","author":"Rajan","year":"2020","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100205_bib0045","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","article-title":"Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study","volume":"2","author":"Verberk","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100205_bib0046","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100205_bib0047","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","article-title":"Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease","volume":"29","author":"Bellaver","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100205_bib0048","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","article-title":"The dynamics of plasma biomarkers across the Alzheimer\u2019s continuum","volume":"15","author":"Guo","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100205_bib0049","article-title":"Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort","volume":"16","author":"Chong","year":"2024","journal-title":"Alzheimer's Dement: Diagn Assess Dis Monit"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100205_bib0050","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","article-title":"Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's disease","volume":"16","author":"Elahi","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100205_bib0051","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1017\/S1355617721000813","article-title":"Lower white matter volume and worse executive functioning reflected in higher levels of plasma GFAP among older adults with and without cognitive impairment","volume":"28","author":"Asken","year":"2022","journal-title":"J Int Neuropsychol Soc"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100205_bib0052","first-page":"e1622","volume":"15","author":"Mu\u00f1oz-Ballester","year":"2023","journal-title":"Astrocyte-Mediat Mech Contrib Trauma Brain Inj Pathol, WIREs Mech Dis"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100205_bib0053","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100205_bib0054","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"S2","key":"10.1016\/j.tjpad.2025.100205_bib0055","doi-asserted-by":"crossref","DOI":"10.1002\/alz.092042","article-title":"Utility of plasma p-tau217 as a secondary outcome for clinical trials across AD continuum","volume":"20","author":"Ferreira","year":"2024","journal-title":"Alzheimer's Dement"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:44:26Z","timestamp":1778867066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2274580725001499"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100205","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100205"}}